Skip to main content
INFUND HOLDING CO.,LTD logo

INFUND HOLDING CO.,LTD — Investor Relations & Filings

Ticker · 002141 ISIN · CNE1000005S1 Shenzhen Stock Exchange Financial and insurance activities
Filings indexed 2,281 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002141

About INFUND HOLDING CO.,LTD

https://www.sz002141.com

INFUND HOLDING CO., LTD. is a multi-sector enterprise group that manages a diverse portfolio across biotechnology, real estate development, and financial services. The organization specializes in life sciences, particularly in the areas of stem cell technology, genetic engineering, and human cryopreservation. Its real estate operations encompass the planning, construction, and management of residential and commercial properties. Furthermore, the company maintains a significant presence in the financial sector through strategic investments, asset management, and capital operations. The firm focuses on the integration of scientific innovation with industrial development to provide specialized services in healthcare and urban infrastructure.

Recent filings

Filing Released Lang Actions
贤丰控股第八届董事会第二十五次会议决议公告
Regulatory Filings
2026-05-06 Chinese
贤丰控股董事会关于独立董事2025年度独立性评估的专项意见
Governance Information Classification · 89% confidence The document is a special opinion issued by the board on the 2025 annual independence assessment of the company’s independent directors, referencing governance rules under CSRC and the Shenzhen Stock Exchange. It is not announcing a board change, nor is it a financial report, earnings release or other category. This is a governance-related disclosure detailing board oversight practices, fitting the Governance Information (CGR) category.
2026-04-21 Chinese
贤丰控股关于2026年董事、高级管理人员薪酬方案的公告
Remuneration Information Classification · 86% confidence The document is an announcement of the remuneration scheme for the company’s directors and senior management, detailing pay structure, performance metrics, and approval requirements. This aligns with disclosures of executive compensation information rather than a notice of board changes or a broader annual/interim report. Therefore, it falls under Remuneration Information (DEF 14A).
2026-04-21 Chinese
贤丰控股2025年度独立董事述职报告(邓延昌)
Regulatory Filings Classification · 65% confidence The document is titled “2025年度独立董事述职报告” and contains a standalone report by an independent director on his annual duties and activities. It is not an AGM notice, proxy statement, financial report (10-K/IR/AR), earnings release, or any other specific category in the taxonomy. It also is not announcing a change in board members or any financing transaction. Therefore it falls into the miscellaneous “Regulatory Filings” fallback category (RNS).
2026-04-21 Chinese
贤丰控股关于举行2025年度网上业绩说明会的公告
Investor Presentation Classification · 85% confidence The document is an announcement (公告) by 昱丰控股股份有限公司 regarding the scheduling and logistics of the company’s 2025 online performance briefing (“业绩说明会”) for investors. It is not the annual report itself nor a transcript or earnings release, but a notice to host an investor presentation to discuss the 2025 results. Such notices fall under Investor Presentation (Code: IP).
2026-04-21 Chinese
贤丰控股关于计提2025年度信用减值损失和资产减值损失的公告
Regulatory Filings Classification · 87% confidence The document is a public announcement by the company’s board detailing the approved 2025 credit and asset impairment provisions per accounting standards. It is not a full annual or interim report, earnings release, dividend notice, governance/proxy statement, or management change notice. It is a routine regulatory filing of an accounting provision decision under exchange rules, fitting the fallback “Regulatory Filings” category.
2026-04-21 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.